Lidia I. Kalyuzhnaya

Prof. Lidia I. Kalyuzhnaya

Kirov Military Medical Academy, Saint Petersburg, Sankt-Peterburg, Russia
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2024 in Biomimetics
Verified
Journal Article
Open access
PDF file
АKАльбина Kondratenko
Альбина Kondratenko
Dmitry TovpekoDmitry Tovpeko
Dmitry Tovpeko
DVDaniil Volov
Daniil Volov
LKLidia I. Kalyuzhnaya
Lidia I. Kalyuzhnaya
VCVladimir E. Chernov
Vladimir E. Chernov
VSVictor I. Sevastianov
Victor I. Sevastianov
The umbilical cord is a material that enhances regeneration and is devoid of age-related changes in the extracellular matrix (ECM). The aim of this work was to develop a biodegradable scaffold from a decellularized human umbilical cord (UC-scaffold) to heal full-thickness wounds. Decellularization was performed with 0.05% sodium dodecyl sulfate solution. The UC-scaffold was studied using morphological analysis methods. The composition of the UC-scaffold was studied using immunoblotting and Fourier transform infrared spectroscopy. The adhesion and proliferation of mesenchymal stromal cells were investigated using the LIVE/DEAD assay. The local reaction was determined by subcutaneous implantation in mice (n = 60). A model of a full-thickness skin wound in mice (n = 64) was used to assess the biological activity of the UC-scaffold. The proposed decellularization method showed its effectiveness in the umbilical cord, as it removed cells and retained a porous structure, type I and type IV collagen, TGF-β3, VEGF, and fibronectin in the ECM. The biodegradation of the UC-scaffold in the presence of collagenase, its stability during incubation in hyaluronidase solution, and its ability to swell by 1617 ± 120% were demonstrated. Subcutaneous scaffold implantation in mice showed gradual resorption of the product in vivo without the formation of a dense connective tissue capsule. Epithelialization of the wound occurred completely in contrast to the controls. All of these data suggest a potential for the use of the UC-scaffold.

1 January 2022 in Профилактическая и клиническая медицина
Verified
Journal Article
Closed access
VKV.V. Khominets
V.V. Khominets
LKLidia I. Kalyuzhnaya
Lidia I. Kalyuzhnaya
AGA.S. Grankin
A.S. Grankin
RFR.F. Fedorov
R.F. Fedorov
DVDaniil Volov
Daniil Volov
AKA.V. Komarov
A.V. Komarov
Традиционные методики замещения костных дефектов в свое время продемонстрировали качественно новый подход к проблеме замещения костных дефектов. По мере их применения открылись некоторые отрицательные стороны традиционных методов и сегодня можно сделать вывод, что существующие традиционные методики замещения значимых дефектов костной ткани не в полной мере удовлетворяют клиницистов, поэтому необходим поиск новых перспективных методик, базирующихся на фундаментальных исследованиях процессов репаративного остеогенеза, некоторые из которых пересматриваются в последние годы. За последние годы накоплен достаточный массив фундаментальных открытий в области тканевой инженерии, которые позволяют рассматривать новые способы восстановления дефектов костной ткани для применения их в клинической практике. Анализ эволюции наиболее распространенных методов замещения костной ткани и поиск перспективных тканеинженерных решений. На основании анализа доступных научных публикаций сравнить современные методики замещения костных дефектов и определить наиболее перспективное направление для исследования и применения в клинической практике. Поиск полноценной альтернативы аутогенной костной ткани приводит к необходимости использования «неординарных» биологически активных материалов, обладающих высокой остеоиндуктивностью. Одной из перспективных методик, на наш взгляд, является использование внеклеточного матрикса из провизорных органов, который так же обладает высокой остеогенной активностью, но при этом безопасен в применении и относительно прост в...

6 September 2024 in Bulletin of the Russian Military Medical Academy
Verified
Journal Article
Open access
PDF file
АKАльбина Kondratenko
Альбина Kondratenko
VCVladimir E. Chernov
Vladimir E. Chernov
Dmitry TovpekoDmitry Tovpeko
Dmitry Tovpeko
DVDaniil Volov
Daniil Volov
NBNikolay V. Beliy
Nikolay V. Beliy
КИКалюжная Лидия Ивановна
Калюжная Лидия Ивановна
The bacteriostatic effects of human umbilical cord-derived matrices and hydrogels were examined. The use of biomimetics based on the extracellular matrix of extraembryonic organs, including the human umbilical cord, is promising for regenerative medicine and tissue engineering. Cell-free products from the extracellular matrix of various human organs and tissues are resistant to intentional bacterial contamination. Two acellular scaffolds prepared using different human umbilical cord decellularization protocols and two derived hydrogels were evaluated for their bacteriostatic properties. Two clinical cases of the use of lyophilisates of umbilical cord-derived hydrogels were described. The compositions of human umbilical cord-derived acellular matrices and hydrogels were studied using biochemical analysis techniques. The sensitivities of Staphylococcus aureus and Escherichia coli to umbilical cord-derived matrices and hydrogels were assessed using culture techniques, and metabolic activities of bacteria were also examined. Human umbilical cord-derived acellular matrices and hydrogels consist of collagens and contain proteins and glycosaminoglycans. A significant bacteriostatic effect of hydrogels against Escherichia coli was detected during the first 16 h of incubation, regardless of the type of detergents used for their preparation. The matrices did not show a bacteriostatic effect, which indicates that the hydrolysis of structural components contributes to the release of substances with bacteriostatic activities. The effect was presumed to be due to the influence on the level of metabolic activity of microorganisms. The use of powdered lyophilized hydrogels derived from human umbilical cord as an adjunct to autodermal graft in the treatment of infected deep wounds in two volunteer patients promoted healing without infections. In general, the use of hydrogel lyophilisates from acellular human umbilical cord as an additional treatment allows for the engraftment of skin autografts and promotes the healing of extensive deep wounds at risk of infection.

15 March 2015 in Pediatrician (St. Petersburg)
Verified
Journal Article
Open access
PDF file
LKLidia I. Kalyuzhnaya
Lidia I. Kalyuzhnaya
DZDmitriy Alekseevich Zemlyanoy
Dmitriy Alekseevich Zemlyanoy
The ability to have a body temperature that is independent of environment temperature is evolutionary acquisition. Thanks to him, organisms can control the intensity of metabolism to increase body temperature. Homoiothermic animals can maintain an optimum body temperature via the heat transfer into the environment. An optimal level of temperature is necessary for activity of most enzymes, the implementation of metabolic reactions in cells. The viscosity of blood and extracellular fluids, the surface tension of the surfactant, swelling colloids of the interstitial space depend on the temperature inside. The excitation of cells, muscle contraction, secretion, absorption, locomotor activity and phagocytic properties of neutrophils also depend on the temperature of the tissues. Fever is pathological process a temporary increasing of body temperature for homoiothermal animals and humans. The process starts due to cytokines exogenous and endogenous origin. Cytokines rebuild the system of thermoregulation. Fever is protective response to damaged but may be redundant. Tachycardia at a fever promotes arrhythmias and may be complicated by the development of acute heart failure. Critical temperature decrease with profuse sweating can cause collapse. Fever in pregnant women in the early stages of placentation provokes violations and defects of the neural tube of the embryo. Fever leads to accumulation of ketonic substances in the blood due to incomplete lipolysis. Ketoacidosis with fever in young patients is the cause of hyperthermic convulsions. The negative effects of fever forced to resort to antipyretic therapy and measures to increase heat dissipation.

7 March 2026 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
SCSergeY Chebotarev
SergeY Chebotarev
Dmitry TovpekoDmitry Tovpeko
Dmitry Tovpeko
LKLidia I. Kalyuzhnaya
Lidia I. Kalyuzhnaya
MKM. E. Kotova
M. E. Kotova
АKАльбина Kondratenko
Альбина Kondratenko
VSV. V. Salukhov
V. V. Salukhov
Non-healing ulcers pose a serious problem for public health due to the high cost of treatment, prolonged disability of patients, and low efficacy of therapy. They are the leading cause of non-traumatic lower limb amputations. The development of innovative bioengineering products is a significant step in the treatment of non-healing diabetic foot ulcers. One such product is a tissue-engineered acellular product made from highly regenerative human umbilical cord biomaterial. It contains growth factors, cytokines, and components of the extracellular matrix of Wharton’s jelly, which accelerates wound healing. THE AIM of this clinical study is to evaluate the safety and efficacy of a tissue-engineered acellular product from Wharton’s jelly of the umbilical cord for the treatment of chronic non-healing lower limb ulcers in patients with diabetic foot syndrome. RESULTS: a 60-year-old woman diagnosed with type 2 diabetes mellitus had chronic ulcers that had not responded to standard treatment for more than a year and a half. She was observed for 4 weeks in August 2024. As a result of the local application of an acellular product from human umbilical cord, signs of reduction in wound size and their complete healing were noted 4 weeks after the start of observation. CONCLUSION: clinical observation has demonstrated the safety and efficacy of the acellular product from human umbilical cord for the treatment of chronic non-healing ulcers of diabetic origin.

30 September 2025 in Russian Military Medical Academy Reports
Verified
Journal Article
Closed access
PDF file
AKAnastasiya A. Kovaleva
Anastasiya A. Kovaleva
YZYunna Yu. Zhidkova
Yunna Yu. Zhidkova
LKLidia I. Kalyuzhnaya
Lidia I. Kalyuzhnaya
Dmitry TovpekoDmitry Tovpeko
Dmitry Tovpeko
YMYuri V. Miroshnichenko
Yuri V. Miroshnichenko
ЖЮЖидкова Юнна Юрьевна
Жидкова Юнна Юрьевна
Burn injuries continue to be a significant concern due to their high prevalence and delayed healing caused by extensive tissue damage and prolonged regeneration. This work focused on a comprehensive analysis of the advantages and disadvantages of existing therapeutic options for burn injuries of varying degrees, as well as promising areas of regenerative medicine. Published data were analyzed to examine pathophysiological mechanisms of burn injuries and their severity grading. Modern burn management includes surgical and topical conservative approaches. Surgical treatment includes necrectomy and skin grafting, which requires donor tissue sites. Topical conservative treatment employs various drugs and medical devices, such as antiseptics, regenerants, and wound dressings. The range of available drugs for burn injury management is limited. These limitations, along with individual disadvantages of existing therapeutic options, necessitate the search for innovative approaches to burn injury management. One promising area is tissue engineering, which uses biologically engineered products to activate a patient’s stem cells. Human umbilical cord Wharton’s jelly is one of the most promising biomaterials. This extraembryonic hard, mucous connective tissue has a remarkable regenerative capacity. Its acellular scaffold promotes cell migration and proliferation, presents growth factors, and stimulates angiogenesis. Human umbilical cord Wharton’s jelly contains collagen, hyaluronic acid, fibronectin, and growth factors that promote regeneration. The proposed technique for producing human umbilical cord-derived acellular scaffold and hydrogel preserves structural and functional components of native human umbilical cord Wharton’s jelly in the finished product. Preclinical and clinical trials have demonstrated the product’s efficacy and safety in treating deep wounds and promoting healing and autograft survival. Human umbilical cord-derived acellular hydrogel is a promising solution for developing new dosage forms and managing burn injuries.